Recombinase-independent AAV for anterograde transsynaptic tracing

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Viral transsynaptic labeling is crucial for understanding neural circuit connectivity in mammals.
• Adeno-associated virus serotype 1 (AAV1) enables anterograde transneuronal labeling but requires genetic access to postsynaptic neurons.
• Current methods are limited by the need for recombinase expression in transgenic animals or specific genetic targeting.

Purpose of the Study:

• To develop a recombinase-independent viral strategy for anterograde transsynaptic labeling.
• To overcome the limitations of existing AAV1-based viral vectors for neural circuit tracing.
• To enhance the efficiency and accessibility of viral tools for studying brain connectivity.

Main Methods:

• Utilized self-complementary adeno-associated virus serotype 1 (scAAV1) under the strong CAG promoter.
• Administered scAAV1 expressing a fluorescent marker in mouse models.
• Investigated anterograde transneuronal labeling in retina-superior colliculus and thalamic-amygdala pathways.

Main Results:

• Demonstrated efficient anterograde transsynaptic labeling using scAAV1.
• Confirmed the recombinase-independent nature of the scAAV1 labeling method.
• Successfully traced neural pathways in the mouse brain, including visual and limbic circuits.

Conclusions:

• scAAV1 provides a powerful, genetically accessible tool for anterograde transsynaptic tracing.
• This method simplifies the investigation of neural connectivity and functional mapping.
• The enhanced expression from scAAV1 opens possibilities for advanced functional imaging studies.